首页> 外文期刊>Genes >Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers
【24h】

Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers

机译:B细胞淋巴瘤的表观遗传异质性:染色质修饰剂

获取原文
           

摘要

We systematically studied the expression of more than fifty histone and DNA (de)methylating enzymes in lymphoma and healthy controls. As a main result, we found that the expression levels of nearly all enzymes become markedly disturbed in lymphoma, suggesting deregulation of large parts of the epigenetic machinery. We discuss the effect of DNA promoter methylation and of transcriptional activity in the context of mutated epigenetic modifiers such as EZH2 and MLL2. As another mechanism, we studied the coupling between the energy metabolism and epigenetics via metabolites that act as cofactors of JmjC-type demethylases. Our study results suggest that Burkitt’s lymphoma and diffuse large B-cell Lymphoma differ by an imbalance of repressive and poised promoters, which is governed predominantly by the activity of methyltransferases and the underrepresentation of demethylases in this regulation. The data further suggest that coupling of epigenetics with the energy metabolism can also be an important factor in lymphomagenesis in the absence of direct mutations of genes in metabolic pathways. Understanding of epigenetic deregulation in lymphoma and possibly in cancers in general must go beyond simple schemes using only a few modes of regulation.
机译:我们系统地研究了淋巴瘤和健康对照中五十多种组蛋白和DNA(去)甲基化酶的表达。作为一项主要结果,我们发现在淋巴瘤中几乎所有酶的表达水平都受到明显干扰,这表明表观遗传机制的大部分失调。我们讨论了在突变的表观遗传修饰子(例如EZH2和MLL2)的背景下DNA启动子甲基化和转录活性的影响。作为另一种机制,我们研究了作为JmjC型脱甲基酶辅因子的代谢物在能量代谢和表观遗传学之间的耦合。我们的研究结果表明,伯基特氏淋巴瘤和弥漫性大B细胞淋巴瘤的区别在于抑制性启动子和平衡启动子的不平衡,这主要由甲基转移酶的活性和脱甲基酶在该法规中的代表性不足所决定。数据进一步表明,在代谢途径中不存在基因的直接突变的情况下,表观遗传学与能量代谢的耦合也可能是淋巴瘤发生的重要因素。一般而言,对淋巴瘤以及可能的癌症中表观遗传失调的理解必须超越仅使用几种调控模式的简单方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号